Moreover, we detected increased expression of PODXL in breast cancer cells in response to IL-4 (35), a cytokine routinely used in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) to differentiate blood derived monocytes into DCs in vitro (36). This evidence concerns the gene CSF2 and breast carcinoma.